Why Smart-ABI?

TEST BOTH ARMS, BOTH LEGS, BOTH POSTERIOR TIBIAL AND DORSALIS PEDIS ARTERIES

AUTOMATICALLY CALCULATES ABI AND SIX ADDITIONAL MEDICAL MARKERS

DISPLAYS ACTUAL BLOOD FLOW, SIX DIFFERENT PRESSURES AND TREND RESULTS OVER TIME

​

​

Smart-ABI

Performs Quantitative Analysis Enabling Early Detection of Peripheral Artery Disease (PAD)

and Peripheral Neuropathy (PN)

PAD is a major cost burden on

the U.S. Healthcare System

​

 The Smart-ABI series

 INSTANTLY

provides quantitative data physicians

can use to identify risk, provide

early detection, and initiate intervention

Smart-ABI is:

• EASY

• IMMEDIATE

• REIMBURSABLE

• PATIENT/PHYSICIAN FRIENDLY REPORT 

• TRENDING ANALYSIS

• COST EFFECTIVE 

• CONVENIENT 

• ACCURATE & REPRODUCIBLE

Smart-ABI eliminates:

• RESCHEDULING

• 30-MINUTE TEST

• CERTIFIED TECHNICIAN

• HARD-TO-READ WAVEFORMS

• WAITING FOR RESULTS

• SPLIT FEES FOR REPORT READING

TEST.  EDUCATE.  PREVENT.

Smart-ABI

AND Smart-ABI Plus

Smart-LEDA

(Lower Extremity Disease Assessment)

​

REIMBURSABLE

PAD Population Profile

age 50+ with history of diabetes

age 70+

age 50+ with history of smoking

It’s not about the number of patients, it’s about the type of patients.  Left untreated, the 5 year mortality rate for these patients is over 30%. It is critical this patient population is tested.